✦ LIBER ✦

Mechanism of Action of Glatiramer Acetate in Treatment of Multiple Sclerosis

✍ Scribed by Martin S. Weber; Reinhard Hohlfeld; Scott S. Zamvil

Book ID: 103869349
Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 137 KB
Volume: 4
Category: Article
ISSN: 1933-7213
DOI: 10.1016/j.nurt.2007.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glatiramer acetate: Mechanisms of action

Glatiramer acetate: Mechanisms of action in multiple sclerosis

✍ Wiebke Schrempf; Tjalf Ziemssen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Mechanisms of action of glatiramer aceta

Mechanisms of action of glatiramer acetate in multiple sclerosis

✍ Neuhaus, O.; Farina, C.; Wekerle, H.; Hohlfeld, R. 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 147 KB

Glatiramer acetate in multiple sclerosis

Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action

✍ Cinthia Farina; Martin S Weber; Edgar Meinl; Hartmut Wekerle; Reinhard Hohlfeld 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 187 KB

Glatiramer Acetate in the Treatment of M

Glatiramer Acetate in the Treatment of Multiple Sclerosis

✍ Lalive, Patrice H.; Neuhaus, Oliver; Benkhoucha, Mahdia; Burger, Danielle; Hohlf 📂 Article 📅 2011 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 218 KB

Glatiramer acetate in the treatment of m

Glatiramer acetate in the treatment of multiple sclerosis

✍ Miller, Aaron E. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 246 KB

[International Review of Neurobiology] T

[International Review of Neurobiology] The Neurobiology of Multiple Sclerosis Volume 79 || Glatiramer Acetate: Mechanisms of Action in Multiple Sclerosis

✍ Ziemssen, Tjalf 📂 Article 📅 2007 🏛 Elsevier 🌐 English ⚖ 408 KB

Multiple sclerosis (MS) is an immune-mediated neurodegenerative disorder of the human central nervous system (CNS) which usually affects young adults with certain genetic backgrounds who are then exposed to certain precipitating environmental antigen(s). Despite major advances of the past two decade